Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Andrews

Showing results (81-90 of 368) with videos related to

Pageof 37
Sort By:
The Journal of Antimicrobial Chemotherapy|January 1, 1993
The in-vitro activity of Bay y 3118, a new chlorofluoroquinoloneR Wise, J M Andrews, N Brenwald
Antimicrobial Agents and Chemotherapy|December 1, 1983
Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibioticsR Wise, J M Andrews, G Danks
The Journal of Antimicrobial Chemotherapy|August 1, 1991
The in-vitro activity of cefdinir (FK482), a new oral cephalosporinR Wise, J M Andrews, D Thornber
Antimicrobial Agents and Chemotherapy|May 1, 1996
In vitro activity of the tricyclic beta-lactam GV104326R Wise, J M Andrews, N Brenwald
Molecular Immunology|March 1, 1981
The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serumC Wehler, J M Andrews, D H Bing
The Journal of Antimicrobial Chemotherapy|June 1, 1992
In-vitro activity of tosufloxacin, a new quinolone antibacterial agentM A Cooper, J M Andrews, R Wise
Internal Medicine Journal|November 14, 2015
Author reply: To PMID 25644364K D Williamson, M Schoeman, J M Andrews
Methods in Enzymology|January 1, 1977
Design of exo affinity labeling reagentsM Cory, J M Andrews, D H Bing
The Journal of General Virology|January 8, 1999
The effect of the cellular stress response on human T-lymphotropic virus type I envelope protein expressionJ M Andrews, M Oglesbee, M D Lairmore
The Journal of Antimicrobial Chemotherapy|May 1, 1992
In-vitro activity of PD 131628, a new quinolone antimicrobial agentM A Cooper, J M Andrews, R Wise
Pageof 37

Showing results (81-90 of 368) with videos related to

Sort By:
Pageof 37
The Journal of Antimicrobial Chemotherapy|January 1, 1993
The in-vitro activity of Bay y 3118, a new chlorofluoroquinoloneR Wise, J M Andrews, N Brenwald
Antimicrobial Agents and Chemotherapy|December 1, 1983
Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibioticsR Wise, J M Andrews, G Danks
The Journal of Antimicrobial Chemotherapy|August 1, 1991
The in-vitro activity of cefdinir (FK482), a new oral cephalosporinR Wise, J M Andrews, D Thornber
Antimicrobial Agents and Chemotherapy|May 1, 1996
In vitro activity of the tricyclic beta-lactam GV104326R Wise, J M Andrews, N Brenwald
Molecular Immunology|March 1, 1981
The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serumC Wehler, J M Andrews, D H Bing
The Journal of Antimicrobial Chemotherapy|June 1, 1992
In-vitro activity of tosufloxacin, a new quinolone antibacterial agentM A Cooper, J M Andrews, R Wise
Internal Medicine Journal|November 14, 2015
Author reply: To PMID 25644364K D Williamson, M Schoeman, J M Andrews
Methods in Enzymology|January 1, 1977
Design of exo affinity labeling reagentsM Cory, J M Andrews, D H Bing
The Journal of General Virology|January 8, 1999
The effect of the cellular stress response on human T-lymphotropic virus type I envelope protein expressionJ M Andrews, M Oglesbee, M D Lairmore
The Journal of Antimicrobial Chemotherapy|May 1, 1992
In-vitro activity of PD 131628, a new quinolone antimicrobial agentM A Cooper, J M Andrews, R Wise
Pageof 37